SCHEMBL5479286

SCHEMBL5479286

O=c1cc[nH]c(=O)n1C(O)O

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2603746 0.78 POLB (0.40) ALDH1A1POLBMAPT
SCHEMBL14861413 0.77 BRD4 (0.32) ALDH1A1POLBMAPT
SCHEMBL5290084 0.76 ALDH1A1 (0.38) ALDH1A1POLBMAPT
SCHEMBL27628887 0.76 MAPT (0.38) ALDH1A1POLBMAPT
SCHEMBL2930014 0.75 BRD4 (0.32) ALDH1A1POLBMAPT
SCHEMBL27989702 0.75 BRD4 (0.32) ALDH1A1POLBMAPT
SCHEMBL301397 0.71 ALDH1A1 (0.35) ALDH1A1POLBMAPT
SCHEMBL28328179 0.71
SCHEMBL237871 0.71 KMT2A (0.31)
SCHEMBL28328177 0.71 GPR84 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293517-A1 Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2007-12-20 US disclosed
WO-2005120577-A2 DERIVATIVES OF CHEMOTHERAPEUTIC AGENTS WITH A FORMALDEHYDE RELEASING MOEITY RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293517-A1 Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety DHFR, FAU, MYD88 ALDH1A1 234/4885POLB 1227/4885MAPT 3532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.